Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R W Stephens

Showing results (41-50 of 93) with videos related to

Pageof 10
Sort By:
British Journal of Cancer|September 25, 1999
Soluble urokinase receptor released from human carcinoma cells: a plasma parameter for xenograft tumour studiesC Holst-Hansen, M J Hamers, B E Johannessen, et al.
Ophthalmic Research|January 1, 1992
Retinal pigment epithelial cells secrete urokinase-type plasminogen activator and its inhibitor PAI-1V Sirén, R W Stephens, E M Salonen, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|June 1, 2000
Plasma Escherichia coli beta-galactosidase as a marker of tumor burden and response to experimental anti-neoplastic therapy in nude mice xenografted with lacZ transduced human tumor cellsC Holst-Hansen, R W Stephens, B E Johannessen, et al.
Biochimica Et Biophysica Acta|May 1, 1979
Neutral protease inhibitors from human intervertebral disc and femoral head articular cartilageJ A Knight, R W Stephens, G R Bushell, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 1, 1990
Prourokinase activation on the surface of human rhabdomyosarcoma cells: localization and inactivation of newly formed urokinase-type plasminogen activator by recombinant class 2 plasminogen activator inhibitorJ Pöllänen, A Vaheri, H Tapiovaara, et al.
Current Eye Research|March 1, 1989
Tissue-type plasminogen activator in subretinal fluidI Immonen, R W Stephens, E M Salonen, et al.
Arzneimittel-Forschung|January 1, 1980
A radioassay for proteolytic cleavage of isolated cartilage proteoglycan. 2. Inhibition of human leukocyte elastase and cathepsin G by anti-inflammatory drugsR W Stephens, E A Walton, P Ghosh, et al.
Journal of Leukocyte Biology|October 1, 1985
Preparation and characterization of human bone marrow-derived macrophagesD A Hume, W Allan, J Golder, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|April 6, 1999
The urokinase plasminogen activator receptor in blood from healthy individuals and patients with cancerN Brünner, H J Nielsen, M Hamers, et al.
Thrombosis Research|April 1, 1997
A peptide sequence from the EGF-2 like domain of FVII inhibits TF-dependent FX activationL Orning, R W Stephens, L B Petersen, et al.
Pageof 10

Showing results (41-50 of 93) with videos related to

Sort By:
Pageof 10
British Journal of Cancer|September 25, 1999
Soluble urokinase receptor released from human carcinoma cells: a plasma parameter for xenograft tumour studiesC Holst-Hansen, M J Hamers, B E Johannessen, et al.
Ophthalmic Research|January 1, 1992
Retinal pigment epithelial cells secrete urokinase-type plasminogen activator and its inhibitor PAI-1V Sirén, R W Stephens, E M Salonen, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|June 1, 2000
Plasma Escherichia coli beta-galactosidase as a marker of tumor burden and response to experimental anti-neoplastic therapy in nude mice xenografted with lacZ transduced human tumor cellsC Holst-Hansen, R W Stephens, B E Johannessen, et al.
Biochimica Et Biophysica Acta|May 1, 1979
Neutral protease inhibitors from human intervertebral disc and femoral head articular cartilageJ A Knight, R W Stephens, G R Bushell, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 1, 1990
Prourokinase activation on the surface of human rhabdomyosarcoma cells: localization and inactivation of newly formed urokinase-type plasminogen activator by recombinant class 2 plasminogen activator inhibitorJ Pöllänen, A Vaheri, H Tapiovaara, et al.
Current Eye Research|March 1, 1989
Tissue-type plasminogen activator in subretinal fluidI Immonen, R W Stephens, E M Salonen, et al.
Arzneimittel-Forschung|January 1, 1980
A radioassay for proteolytic cleavage of isolated cartilage proteoglycan. 2. Inhibition of human leukocyte elastase and cathepsin G by anti-inflammatory drugsR W Stephens, E A Walton, P Ghosh, et al.
Journal of Leukocyte Biology|October 1, 1985
Preparation and characterization of human bone marrow-derived macrophagesD A Hume, W Allan, J Golder, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|April 6, 1999
The urokinase plasminogen activator receptor in blood from healthy individuals and patients with cancerN Brünner, H J Nielsen, M Hamers, et al.
Thrombosis Research|April 1, 1997
A peptide sequence from the EGF-2 like domain of FVII inhibits TF-dependent FX activationL Orning, R W Stephens, L B Petersen, et al.
Pageof 10